Bacterial infection is linked to the etiology of periodontal diseaes; however, the role of miroorganisms in the pathogenesis of these disorders is not clear. One proposed mechanism by which suspected periodontopathogens may act to cause disease is the impairment of host defenses. In this regard, we have domonstrated the presence of non-cytotoxic immunosuppressive factors in the soluble sonic extracts of several strains of Actinobacillus actinomycetemcomitans, Treponema denticola and Fusobacterium nucleatum. Based on both our findings and evidence from several clinical studies, we propose that immune dysfunction may play a role in the etiology of periodontal disease and be linked to the immunosuppressive ability of periodontopathogens.
The specific aims of this proposal are: 1) to evaluate suspected periodontopathogens for their ability to inhibit lymphocyte responses; 2) to fully characterize these inhibitory factors for their ability to alter T-cell and monocyte/macrophage function; 3) to purify and physiochemically characterize these bacterial agents; 4) to determine the mode of action of these immunosupressive factors; and 5) to test the inhibitory factors for their ability to depress immune function in vivo. For these studies, human peripheral blood lymphocytes will be utilized in a series of in vitro assays in order to asess sevral parameters of immune function. The factors will also be administered to rats either IV, IP or ID in order to assess effects on in vivo parameters of immune function (both cell mediated and humoral immunity). The fundamental hypothesis to be tested is that certain plaque associated bacteria may produce factors that cause immunosuppression the effects of which might be to enhance their own pathogenicity or that of other opportunistic organisms. It is anticipated that these studies will provide a basis for future clinical investigations that could directly implicate such suppressive factors in the pathogenesis of periodontal disease. Furthermore, these studies may provide a rationale and basis for the early detection and prevention of disease as well as for alternative approaches to therapeutic intervention and management of these patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
2R01DE006014-04
Application #
3219736
Study Section
Oral Biology and Medicine Study Section (OBM)
Project Start
1982-08-01
Project End
1990-07-31
Budget Start
1985-08-01
Budget End
1986-07-31
Support Year
4
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Dentistry/Oral Hygn
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Boesze-Battaglia, Kathleen; Walker, Lisa P; Dhingra, Anuradha et al. (2017) Internalization of the Active Subunit of the Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin Is Dependent upon Cellugyrin (Synaptogyrin 2), a Host Cell Non-Neuronal Paralog of the Synaptic Vesicle Protein, Synaptogyrin 1. Front Cell Infect Microbiol 7:469
Leonard, Stephanie A; Petito, Lucia C; Stephansson, Olof et al. (2017) Weight gain during pregnancy and the black-white disparity in preterm birth. Ann Epidemiol 27:323-328.e1
Shenker, Bruce J; Boesze-Battaglia, Kathleen; Scuron, Monika Damek et al. (2016) The toxicity of the Aggregatibacter actinomycetemcomitans cytolethal distending toxin correlates with its phosphatidylinositol-3,4,5-triphosphate phosphatase activity. Cell Microbiol 18:223-43
Scuron, Monika D; Boesze-Battaglia, Kathleen; Dlaki?, Mensur et al. (2016) The Cytolethal Distending Toxin Contributes to Microbial Virulence and Disease Pathogenesis by Acting As a Tri-Perditious Toxin. Front Cell Infect Microbiol 6:168
Shenker, B J; Walker, L P; Zekavat, A et al. (2016) Lymphoid susceptibility to the Aggregatibacter actinomycetemcomitans cytolethal distending toxin is dependent upon baseline levels of the signaling lipid, phosphatidylinositol-3,4,5-triphosphate. Mol Oral Microbiol 31:33-42
Boesze-Battaglia, Kathleen; Walker, Lisa P; Zekavat, Ali et al. (2015) The Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin Active Subunit CdtB Contains a Cholesterol Recognition Sequence Required for Toxin Binding and Subunit Internalization. Infect Immun 83:4042-55
Shenker, Bruce J; Ojcius, David M; Walker, Lisa P et al. (2015) Aggregatibacter actinomycetemcomitans cytolethal distending toxin activates the NLRP3 inflammasome in human macrophages, leading to the release of proinflammatory cytokines. Infect Immun 83:1487-96
Shenker, Bruce J; Walker, Lisa P; Zekavat, Ali et al. (2014) Blockade of the PI-3K signalling pathway by the Aggregatibacter actinomycetemcomitans cytolethal distending toxin induces macrophages to synthesize and secrete pro-inflammatory cytokines. Cell Microbiol 16:1391-404
Shenker, Bruce J; Ali, Hydar; Boesze-Battaglia, Kathleen (2011) PIP3 regulation as promising targeted therapy of mast-cell-mediated diseases. Curr Pharm Des 17:3815-22
Shenker, Bruce J; Boesze-Battaglia, Kathleen; Zekavat, Ali et al. (2010) Inhibition of mast cell degranulation by a chimeric toxin containing a novel phosphatidylinositol-3,4,5-triphosphate phosphatase. Mol Immunol 48:203-10